innoscripta SE (ISIN: DE000A40QVM8) has announced its expansion into the United Kingdom, following its successful market entry into France earlier this year. The German software company has established a local sales team and already secured its first UK customer, a software firm with annual revenues in the mid-double-digit million euro range, which will use innoscripta's SaaS platform Clusterix to support its R&D tax relief claims.
Clusterix has been fully adapted to UK regulatory requirements, enabling companies to systematically capture R&D projects, working hours, and eligible costs while creating a comprehensive, audit-ready documentation trail. This capability is increasingly important as HM Revenue & Customs (HMRC) has substantially tightened its documentation and compliance requirements for R&D tax relief claims in recent years.
The United Kingdom represents a significant market opportunity for innoscripta. With annual R&D tax reliefs of approximately EUR 8.7 billion (around 0.3% of GDP), the UK is Europe's second-largest R&D tax incentive market after France, and roughly seven times larger than Germany. innoscripta plans to significantly expand both its UK sales organisation and customer base by the end of the year, with several additional customer engagements already at an advanced stage of negotiations.
This expansion marks another milestone in innoscripta's international growth strategy. The company previously entered the French market, as announced in an April 2026 news release. By targeting the UK, innoscripta aims to capitalize on the growing demand for digital solutions that help businesses navigate complex R&D tax relief regulations. The Clusterix platform offers a scalable solution for managing innovation projects, digitizing internal processes, and making R&D activities transparent and scalable.
For businesses in the UK, particularly those in the software and technology sectors, innoscripta's entry provides a new tool to streamline R&D tax relief claims. The tightened HMRC requirements have made it more challenging for companies to claim relief without robust documentation. Clusterix addresses this by providing an audit-ready trail, potentially reducing the risk of denied claims or penalties.
innoscripta SE is headquartered in Tutzing, Germany, and offers Clusterix as a scalable software platform for the structured organization and management of research and development activities. The company's expansion into the UK underscores its commitment to serving European markets with high R&D tax incentive activity.
